Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B.
Thodoris VoulgarisMargarita PapatheodoridiPietro LamperticoGeorgios PapatheodoridisPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Direct comparison of the newest HCC risk scores in independent patient cohorts of different origin remains intriguing, although statistical associations may not be directly transferable to clinical practice. PAGE-B and recently mPAGE-B score seem to offer persistently high predictability for Caucasian and/or Asian treated patients with low HCC risk who require no surveillance.